
In Memoriam
Remembering two of Baird's most respected leaders, G. Fred Kasten and Paul Purcell.
A Baird Capital portfolio company is contributing to the effort to end the global COVID-19 pandemic.
Baird Capital, our private equity and venture capital fund business, has an investment in NeuMoDx Molecular, a molecular diagnostics and solutions company. We are pleased that NeuMoDx recently received FDA emergency use approval for a test for SARS-CoV-2, the virus that causes COVID-19.
To learn more visit bairdcapital.com.
Financial moves to make to help protect your wealth, both now and over the long term.
The economic experts at Strategas on what to expect from the recovery.